Epigenetics in Lung Cancer: From the Bench to the Beside, Oct. 7 Seminar
Join the BUSM Pulmonary Center on Thursday, Oct. 7, as it hosts distinguished visitor, Vice President for Research and Director of the Lung Cancer/Population Sciences Programs at the University of New Mexico Cancer Center in Albuquerque Steven Belinsky, PhD. Dr. Belinsky will speak on “Epigenetics in Lung Cancer: From the Bench to the Bedside.” This seminar will be held in the Housman Research (R) building, Conference room R-309, from 10 – 11:00 AM.
Dr. Belinsky has worked in the field of tobacco carcinogenesis for more than 20 years and is internationally recognized for his work in lung cancer and translational studies for early detection of lung cancer. His laboratory was the first to demonstrate that the tobacco specific nitrosamine causes DNA adducts that accumulate in the lung and lead to mutation of the K-ras oncogene. Dr. Belinsky’s work has been extended to evaluate epigenetic mechanisms for lung cancer, specifically inactivation of genes through aberrant promoter hypermethylation.
Dr. Belinsky received his undergraduate training and graduate degrees at the University of North Carolina at Chapel Hill. He then did a postdoctoral fellowship and was a Senior Staff fellow at the National Institute of Environmental Health Sciences before moving to the Lovelace Respiratory Research Institute in Albuquerque in 1990.
He currently serves as Vice President for Research, Director of the Lung Cancer Program, and co-directs the Cancer Population Sciences Program for the University of New Mexico Cancer Center. He has served on numerous advisory boards for the National Institute of Environmental Health Sciences and the National Cancer Institute and has authored more than 160 publications.